Citadel Advisors LLC Takes Position in Context Therapeutics Inc. (NASDAQ:CNTX)
Citadel Advisors LLC bought a new stake in Context Therapeutics Inc. (NASDAQ:CNTX – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 29,900 shares of the company’s stock, valued at approximately $31,000. Several other large investors have also […]
Citadel Advisors LLC bought a new stake in Context Therapeutics Inc. (NASDAQ:CNTX – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 29,900 shares of the company’s stock, valued at approximately $31,000. Several other large investors have also […]
